Profil
Curt H.
LaBelle is currently Chairman-Steering Committee at Serum Institute of India Pvt Ltd. since 2017.
Director at Vedanta Biosciences, Inc. since 2023.
Director at KeepYourSight Foundation, Ophirex, Inc., Revelation Biosciences Sub, Inc. since 2021, CXL Ophthalmics LLC since 2022, Atticus Medical Pty Ltd. since 2015, IanTech, Inc. since 2015, and Adjuvant Capital LP.
Venture Partner.
President & Managing Partner at Global Health Investment Fund since 2015.
Board Member at Maternal Newborn Health Innovations PBC since 2022.
Managing Partner at AXA IM Alts since 2022.
Former roles include Chairman at NuVasive Clinical Services Monitoring, Inc. (2008–2011), SafeOp Surgical, Inc. (2011–2015), Exagen, Inc. (2009–2015), and Alydia Health, Inc. (2018–2021).
Director at KAI Pharmaceuticals, Inc. (2006–2012), Sirion Therapeutics, Inc. (2006–2008), Atomo Diagnostics Ltd. (2016–2023), Hyperion DeFi, Inc. (2015–2022), and Revelation Biosciences, Inc. (2021–2023).
Partner & Managing Director at Tullis Health Investors, Inc. (2010–2015).
Managing Director at Global Health Investment Advisors LLC (2008–2015).
Vice President at Investor Growth Capital LLC (2005–2008) and Patricia Industries AB (2005–2007).
Senior Associate at Tullis Health Investors, Inc. (2002–2005).
Director at Vidacare Corp., Coherex Medical, Inc., Endoscopic Technologies, Inc., TransMolecular, Inc.Education includes a doctorate and an MBA from The Trustees of Columbia University in The City of New York and Columbia Business School, both conferred in 1999, and an undergraduate degree from Brigham Young University in 1994.
Postes actifs de Curt LaBelle
| Sociétés | Poste | Début |
|---|---|---|
KeepYourSight Foundation
KeepYourSight Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Directeur/Membre du Conseil | - |
Revelation Biosciences Sub, Inc.
Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Directeur/Membre du Conseil | 01/01/2021 |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences. It provides equity, mezzanine and debt financing for later stage capital requirements with an investment size of USD 10 to 25 million. | Private Equity Investor | - |
Atticus Medical Pty Ltd. | Directeur/Membre du Conseil | 01/09/2015 |
Ophirex, Inc.
Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antidotes to snakebite | Directeur/Membre du Conseil | - |
IanTech, Inc.
IanTech, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic devices | Private Equity Investor | 01/06/2015 |
Serum Institute of India Pvt Ltd.
Serum Institute of India Pvt Ltd. BiotechnologyHealth Technology Manufactures vaccines and immunobiological products | Private Equity Investor | 01/06/2017 |
Maternal Newborn Health Innovations Corp.
Maternal Newborn Health Innovations Corp. Medical/Nursing ServicesHealth Services Engages in improving the health of pregnant women and children | Directeur/Membre du Conseil | 01/07/2022 |
CXL Ophthalmics LLC
CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services Develops a treatment for eyecare | Directeur/Membre du Conseil | 01/10/2022 |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Curt LaBelle
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Curt LaBelle
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 31 |
|---|---|
KAI Pharmaceuticals, Inc.
KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops biopharmaceutical drugs | Health Technology |
Vidacare Corp.
Vidacare Corp. Medical SpecialtiesHealth Technology Develops, manufactures, and markets intraosseous access devices | Health Technology |
Coherex Medical, Inc.
Coherex Medical, Inc. Medical SpecialtiesHealth Technology Designs, develops and markets catheter-based technologies for the treatment of certain structural heart defects | Health Technology |
NuVasive Clinical Services Monitoring, Inc.
NuVasive Clinical Services Monitoring, Inc. Medical/Nursing ServicesHealth Services Provides intra-operative neurophysiologic monitoring services | Health Services |
SafeOp Surgical, Inc.
SafeOp Surgical, Inc. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
Investor Growth Capital LLC | |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Tullis Health Investors, Inc.
Tullis Health Investors, Inc. Investment ManagersFinance Tullis Health invests in companies located in the US. The firm focuses on medical device, healthcare services, specialty pharmaceuticals and biotechnology sectors. It participates in late and growth transactions. | Finance |
Endoscopic Technologies, Inc.
Endoscopic Technologies, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices | Health Technology |
Brigham Young University
Brigham Young University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransMolecular, Inc.
TransMolecular, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes novel & proprietary products | Health Technology |
Exagen, Inc.
Exagen, Inc. Medical/Nursing ServicesHealth Services Operates as a commercial-stage diagnostics company | Health Services |
Sirion Therapeutics, Inc.
Sirion Therapeutics, Inc. BiotechnologyHealth Technology Provides biopharmaceutical products and services | Health Technology |
Serum Institute of India Pvt Ltd.
Serum Institute of India Pvt Ltd. BiotechnologyHealth Technology Manufactures vaccines and immunobiological products | Health Technology |
Atomo Diagnostics Ltd.
Atomo Diagnostics Ltd. Medical SpecialtiesHealth Technology Manufactures and markets blood testing vitro diagnostic medical devices | Health Technology |
Vedanta Biosciences, Inc.
Vedanta Biosciences, Inc. BiotechnologyHealth Technology Develops microbial therapies that address the human immune system | Health Technology |
KeepYourSight Foundation
KeepYourSight Foundation Investment Trusts/Mutual FundsMiscellaneous Functions as a foundation or endowment | Miscellaneous |
Patricia Industries AB
Patricia Industries AB Investment ManagersFinance Patricia Industries invests in companies located in the Nordic region and North America. The firm focuses on a broad range of sectors and industries. It provides financing for buyout capital transactions. | Finance |
Columbia Business School
Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Health Investment Fund
Global Health Investment Fund Investment ManagersFinance Acts as Family of Funds | Finance |
Eyenovia, Inc.
Eyenovia, Inc. Pharmaceuticals: MajorHealth Technology Delivers sight saving therapies | Health Technology |
Global Health Investment Advisors LLC
Global Health Investment Advisors LLC Investment ManagersFinance Functions as an alternative investment manager | Finance |
IanTech, Inc.
IanTech, Inc. Medical SpecialtiesHealth Technology Develops ophthalmic devices | Health Technology |
Alydia Health, Inc.
Alydia Health, Inc. Medical SpecialtiesHealth Technology Manufactures and distributes medical devices | Health Technology |
Ophirex, Inc.
Ophirex, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antidotes to snakebite | Commercial Services |
Adjuvant Capital LP
Adjuvant Capital LP Investment ManagersFinance Adjuvant Capital invests in companies located in the United States. The firm targets companies operating in the fields of life sciences. It provides equity, mezzanine and debt financing for later stage capital requirements with an investment size of USD 10 to 25 million. | Finance |
Revelation Biosciences Sub, Inc.
Revelation Biosciences Sub, Inc. Medical SpecialtiesHealth Technology Develops medical devices | Health Technology |
CXL Ophthalmics LLC
CXL Ophthalmics LLC Medical/Nursing ServicesHealth Services Develops a treatment for eyecare | Health Services |
Revelation Biosciences, Inc.
Revelation Biosciences, Inc. BiotechnologyHealth Technology Develops therapeutics and diagnostics for viral infections | Health Technology |
Atticus Medical Pty Ltd. | |
Maternal Newborn Health Innovations Corp.
Maternal Newborn Health Innovations Corp. Medical/Nursing ServicesHealth Services Engages in improving the health of pregnant women and children | Health Services |
















